Chinese audiologists' attitudes toward MSTB adoption are informative for protocol harmonization efforts, but this retrospective survey does not itself provide evidence sufficient to change existing cochlear implant testing practices.
Standardizing speech testing for cochlear implant users across international clinical settings is essential for comparing outcomes and guiding rehabilitation, and understanding barriers to MSTB adoption in China could accelerate that harmonization.
- 01Reviews the revised Minimum Speech Test Battery (MSTB) for adult cochlear implant users.
- 02Surveys Chinese audiologists on awareness of and responses to the updated MSTB.
- 03Highlights potential gaps between international testing standards and current Chinese clinical practice.
- 04Retrospective design limits causal conclusions about adoption drivers.
- 05Findings are relevant to efforts to standardize cochlear implant outcome measurement globally.
The revised MSTB represents an updated standard for assessing speech recognition in adult cochlear implant users.
guidelinesupportedChinese audiologists have varying levels of adoption of the revised MSTB in clinical practice.
studypartially supported- PMID
- 42103641
- DOI
- 10.3760/cma.j.cn115330-20250812-00420.
- Journal
- Chinese Journal of Otorhinolaryngology Head and Neck Surgery
- Publication type
- research_article
- Evidence level
- 4
- Population
- Adult cochlear implant users and Chinese audiologists
- Intervention
- Revised Minimum Speech Test Battery (MSTB) for adult cochlear implant users
Primary outcomes
Chinese audiologist awareness of and responses to the revised MSTB; Patterns of MSTB adoption in Chinese audiology clinical practice